|
|
|
World Courier
|
Customising the Cold Chain
|
Of all the statistics emerging around the global pharmaceutical industry
this year, two big numbers capture the attention of both manufacturers
and their logistics partners: $248 billion, the amount the “BRIC”
nations (Brazil, Russia, India and China) are poised to account for in
pharmaceutical sales for by 2016; and $8 billion, the amount global
pharma will spend on cold chain logistics in 2014. Why are these two
numbers so noteworthy? They demonstrate that as R&D goes, so goes
logistics. As products evolve to meet demands for more targeted
therapies, demand for more targeted logistics solutions grows as well.
And that means a need for customization for everything from clinical
trial samples to finished product.
|
|
|
|
|
 |
 |
News and Press Releases |
 |
AirBridgeCargo Airlines Expands Its Partnership With Sonoco Thermosafe To Embrace New Pegasus Uld Passive Container
AirBridgeCargo Airlines, part of Volga-Dnepr Group, expands its Master
Lease Agreement with Sonoco ThermoSafe to enable its customers worldwide
to transport life-saving and healthcare products within Pegasus ULD
passive container (passive container – ULD capable to maintain internal
temperature environment during a certain period of time without charge).
The latest Sonoco addition to a sophisticated product family will
guarantee secure, trackable, and reliable transportation of
temperature-sensitive pharmaceutical shipments of up to 998 kg.
More info >> |
|
 |
White Papers |
 |
The Rare Disease Patients Experience
When planning a clinical trial for a rare disease, it is important to have a holistic understanding of your patient population. You want to be aware of where your patients are coming from, and what it is like to walk in their shoes. These patients need your trial just as much as you need them; even from the earliest stages, conceptualize your rare disease trial as an altruistic relationship between the patient population and your study.
More info >> |
|
 |
Industry Events |
 |
DIA Europe 2021
15-19 March 2021, VIRTUAL CONFERENCE
DIA Europe is the must-attend event for all life science professionals
working in drug development, from discovery to marketed use. It
encourages open collaboration by bringing together representatives from
the entire spectrum of the life science landscape and facilitating
crucial discussions across several topic tracks: Clinical Development,
Regulatory Strategy, Pharmacovigilance, Value and Access, Health Policy,
and many more.
More info >> |
|
|
|